Periodic Breathing
8
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Detection of Respiratory Events Using Acoustic Monitoring in Extremely Preterm Infants
Different Loop Gain Phenotypes in Patients With Chronic Systolic Heart Failure and Periodic Breathing
Arterial Oxygen Saturation on Ventilatory Stability in Extremely Premature Infants
Comparison of Modified With Conventional Adaptive Servoventilation Processes
Modified Adaptive Servoventilation (ASV) Compared to Conventional ASV
Chronic Evaluation of Respicardia Therapy
Developing a New, Dynamic, Therapeutic Pacemaker Algorithm for Stabilising Periodic Breathing in Chronic Heart Failure.
The Cyclocapnic Method for Measurement of Chemosensitivity